Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Ethnicity & Disease
|
June 30, 2015
Lean Mass and Fat Mass as Contributors to Physical Fitness in an Overweight and Obese African American Population
Lisa R Yanek, Dhananjay Vaidya, Brian G Kral, et al.
Family & Community Health
|
August 19, 2016
Impact of Self-Preference Community Fitness Interventions in High-Risk African Americans
Lisa R Yanek, Dhananjay Vaidya, Brian G Kral, et al.
JAMA
|
February 12, 1992
The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial
R E Fried, D M Levine, P O Kwiterovich, et al.
Preventive Cardiology
|
February 8, 2002
Dietary Counseling for High Blood Cholesterol in Families at Risk of Coronary Disease
T F Moy, L R Yanek, J V Raqueño, et al.
The American Journal of Cardiology
|
January 31, 2006
Comparison of coronary calcium and stress myocardial perfusion imaging in apparently healthy siblings of individuals with premature coronary artery disease
Roger S Blumenthal, Diane M Becker, Lisa R Yanek, et al.
Circulation
|
February 13, 2003
Detecting occult coronary disease in a high-risk asymptomatic population
Roger S Blumenthal, Diane M Becker, Lisa R Yanek, et al.
Diabetes Research and Clinical Practice
|
May 24, 2006
Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease
Stasia S Reynolds, Lisa R Yanek, Dhananjay Vaidya, et al.
American Journal of Human Genetics
|
April 2, 2003
KLOTHO allele status and the risk of early-onset occult coronary artery disease
Dan E Arking, Diane M Becker, Lisa R Yanek, et al.
American Journal of Hematology
|
October 14, 2010
A common variant in the Von Willebrand factor gene is associated with multiple functional consequences
Dhananjay Vaidya, Lisa R Yanek, J Enrique Herrera-Galeano, et al.
Journal of Clinical Pharmacy and Therapeutics
|
December 7, 2010
Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects
F Huang, L Allen, D B Huang, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Ethnicity & Disease
|
June 30, 2015
Lean Mass and Fat Mass as Contributors to Physical Fitness in an Overweight and Obese African American Population
Lisa R Yanek, Dhananjay Vaidya, Brian G Kral, et al.
Family & Community Health
|
August 19, 2016
Impact of Self-Preference Community Fitness Interventions in High-Risk African Americans
Lisa R Yanek, Dhananjay Vaidya, Brian G Kral, et al.
JAMA
|
February 12, 1992
The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial
R E Fried, D M Levine, P O Kwiterovich, et al.
Preventive Cardiology
|
February 8, 2002
Dietary Counseling for High Blood Cholesterol in Families at Risk of Coronary Disease
T F Moy, L R Yanek, J V Raqueño, et al.
The American Journal of Cardiology
|
January 31, 2006
Comparison of coronary calcium and stress myocardial perfusion imaging in apparently healthy siblings of individuals with premature coronary artery disease
Roger S Blumenthal, Diane M Becker, Lisa R Yanek, et al.
Circulation
|
February 13, 2003
Detecting occult coronary disease in a high-risk asymptomatic population
Roger S Blumenthal, Diane M Becker, Lisa R Yanek, et al.
Diabetes Research and Clinical Practice
|
May 24, 2006
Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease
Stasia S Reynolds, Lisa R Yanek, Dhananjay Vaidya, et al.
American Journal of Human Genetics
|
April 2, 2003
KLOTHO allele status and the risk of early-onset occult coronary artery disease
Dan E Arking, Diane M Becker, Lisa R Yanek, et al.
American Journal of Hematology
|
October 14, 2010
A common variant in the Von Willebrand factor gene is associated with multiple functional consequences
Dhananjay Vaidya, Lisa R Yanek, J Enrique Herrera-Galeano, et al.
Journal of Clinical Pharmacy and Therapeutics
|
December 7, 2010
Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects
F Huang, L Allen, D B Huang, et al.
Page
of 7